Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Clinical Utility of Expanded Carrier Screening: Results-Guided Actionability and Outcomes

Version 1 : Received: 31 July 2018 / Approved: 1 August 2018 / Online: 1 August 2018 (12:07:35 CEST)

A peer-reviewed article of this Preprint also exists.

Johansen Taber, K.A.; Beauchamp, K.A.; Lazarin, G.A.; Muzzey, D.; Arjunan, A.; Goldberg, J.D. Clinical Utility of Expanded Carrier Screening: Results-Guided Actionability and Outcomes. Obstetrical & Gynecological Survey 2019, 74, 582–584, doi:10.1097/01.ogx.0000585316.89683.ad. Johansen Taber, K.A.; Beauchamp, K.A.; Lazarin, G.A.; Muzzey, D.; Arjunan, A.; Goldberg, J.D. Clinical Utility of Expanded Carrier Screening: Results-Guided Actionability and Outcomes. Obstetrical & Gynecological Survey 2019, 74, 582–584, doi:10.1097/01.ogx.0000585316.89683.ad.

Abstract

Purpose: Expanded carrier screening (ECS) informs couples of their risk of having offspring affected by certain genetic conditions. Limited data exists assessing the actions and reproductive outcomes of at-risk couples (ARCs). We describe the impact of ECS on planned and actual pregnancy management in the largest sample of ARCs studied to date. Methods: Couples who elected ECS and were found to be at high risk of having a pregnancy affected by at least one of 176 genetic conditions were invited to complete a survey about their actions and pregnancy management. Results: Three hundred ninety-one ARCs completed the survey. Among those screened before becoming pregnant, 77% planned or pursued actions to avoid having affected offspring. Among those screened during pregnancy, 37% elected prenatal diagnostic testing (PNDx) for that pregnancy. In subsequent pregnancies that occurred in both the preconception and prenatal screening groups, PNDx was pursued in 29%. The decision to decline PNDx was most frequently based on the fear of procedure-related miscarriage, as well as the belief that termination would not be pursued in the event of a positive diagnosis. Conclusions: ECS results impacted couples’ reproductive decision-making and led to altered pregnancy management that effectively eliminates the risk of having affected offspring.

Keywords

expanded carrier screening; prenatal diagnosis; pregnancy management; clinical utility; at-risk couple

Subject

Medicine and Pharmacology, Obstetrics and Gynaecology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.